Utang jangka cendhak marang modal: Concord Medical Services (CCM)

Concord Medical Services (CCM) is developing premium oncology centers in China, where high leverage is already priced in, with the current indicator standing at 0.00. The business relies on the ownership of unique radiotherapy infrastructure, ensuring a perpetual influx of clients. A reliable cash flow is generated through government contracts and steady demand for therapy, as clearly demonstrated by this market valuation chart.

The investor assesses the margin of safety for Concord Medical Services (CCM) through the ratio of current liabilities to equity, which allows for the identification of hidden liquidity risks. The implementation of AI modules and billing automation requires strict control over current liabilities; therefore, analyzing the ratio of short-term liabilities to equity determines the stability of Concord Medical Services (CCM) as an asset with a moderate credit profile.